NDAINHALATIONAEROSOL, METERED
Approved
Mar 1956
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
ISOPROTERENOL HYDROCHLORIDE (isoproterenol hydrochloride) by Medica Corp is beta-adrenergic agonist with very low affinity for alpha-adrenergic receptors. First approved in 1956.
Drug data last refreshed 3d ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Isoproterenol hydrochloride is a beta-adrenergic agonist administered via metered-dose aerosol inhalation, with very low affinity for alpha-adrenergic receptors. It is indicated for bronchospasm and acute asthma, acting as a rapid-onset bronchodilator. The drug has been a foundational therapy in acute respiratory care since its approval in 1956.
LOE Approaching
This legacy product is approaching loss of exclusivity with modest competitive pressure (30/100), indicating a contracting team focused on transition planning rather than growth initiatives.
Mechanism of Action
beta-adrenergic agonist with very low affinity for alpha-adrenergic receptors.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on isoproterenol offers limited growth trajectory but strong foundational experience in managing legacy products through LOE transitions. Professionals should expect focus on operational efficiency, cost management, and stakeholder communication rather than expansion or innovation.
Brand ManagerRegulatory Affairs Specialist
Worked on ISOPROTERENOL HYDROCHLORIDE at Medica Corp? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.